Results 11 to 20 of about 545 (124)

Improvement of sleep and melatonin in children with autism spectrum disorder after β-1,3/1,6-glucan consumption: An open-label prospective pilot clinical study. [PDF]

open access: yesBrain Behav, 2022
Abstract Introduction Poor sleep quality is a major problem in patients with autism spectrum disorder (ASD), and is attributed to low melatonin levels. Melatonin supplementation is recommended; however, its effectiveness varies. β‐Glucans have previously been shown to improve melatonin levels in animal studies.
Raghavan K   +9 more
europepmc   +2 more sources

Association of Diet and Calcium Tartrate Tetrahydrate Uroliths in Dogs. [PDF]

open access: yesJ Vet Intern Med
ABSTRACT Background Calcium tartrate tetrahydrate (CTT) uroliths are recently identified in dogs. Objectives To report on the types and prevalence of diets, supplements, and medications containing salts of tartaric acid consumed by dogs with CTT urolithiasis.
Lulich J, Koehler L, Ulrich L, Furrow E.
europepmc   +2 more sources

Successful Anesthetic Management of an Adult with Sotos Syndrome. [PDF]

open access: yesCase Rep Anesthesiol, 2022
Sotos syndrome is a rare genetic disorder presenting with craniofacial abnormalities, profound hypotonia, and cardiac abnormalities, giving rise to several potential challenges and concerns for an anesthesiologist. When preparing for a Sotos syndrome patient’s case, we consulted the literature for precedents on how to plan the anesthetic, to which we ...
Winegarner A, Kendall MC, Lecamwasam H.
europepmc   +2 more sources

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. [PDF]

open access: yesGeriatr Gerontol Int
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Mogi M   +4 more
europepmc   +2 more sources

Medicines and driving in older people

open access: yesJournal of Pharmacy Practice and Research, Volume 52, Issue 3, Page 254-262, June 2022., 2022
Abstract Many prescribed medicines can impair driving skills, at any age. Each year in Australia approximately 250 people aged 65 and over die from road crashes and approximately 4000 more are hospitalised. Older people are more likely to have comorbidities and require multiple medicines.
Jennifer A Gowan
wiley   +1 more source

Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use?

open access: yesBritish Journal of Clinical Pharmacology, Volume 87, Issue 10, Page 3978-3987, October 2021., 2021
Aims Antihistamines are routinely taken to control allergic reactions or sedation to induce sleep. There are, however, growing concerns regarding sedating antihistamine misuse. This research aims to evaluate deaths related to antihistamines in England occurring during 2000–2019. Methods Cases reported to the National Programme on Substance Abuse Deaths
Princess J. Oyekan   +2 more
wiley   +1 more source

Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective

open access: yesNeuropsychopharmacology Reports, Volume 41, Issue 3, Page 352-361, September 2021., 2021
There was gender difference in the factors associated with the level of prolactin in patients under remission from alcohol use disorder. Only in the female patients, alcohol use trait‐related factors were associated with the level of prolactin, whereas no association was observed with the alcohol use state‐related factors in either gender.
Susmita Pandey   +3 more
wiley   +1 more source

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs

open access: yesPharmacology Research &Perspectives, Volume 9, Issue 3, June 2021., 2021
This review examines the effects of age, sex and genetic polymorphisms on the pharmacokinetics (absorption, distribution, metabolism, excretion) of anticholinergic medications. Increased drug exposure increases risk of adverse drug events; including cognitive impairment which is associated with anticholinergic medication use. Abstract There is evidence
Shanna C. Trenaman   +3 more
wiley   +1 more source

Drug‐induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 19, Issue 1, Page 19-29, January 2021., 2021
Summary Drug‐induced photosensitivity, the development of phototoxic or photoallergic reactions due to pharmaceuticals and subsequent exposure to ultraviolet or visible light, is an adverse effect of growing interest. This is illustrated by the broad spectrum of recent investigations on the topic, ranging from molecular mechanisms and culprit drugs ...
Georg Amun Hofmann, Benedikt Weber
wiley   +1 more source

Medikamenten‐induzierte Photosensibilität: auslösende Medikamente, mögliche Mechanismen und klinische Folgen

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 19, Issue 1, Page 19-30, January 2021., 2021
Zusammenfassung Medikamenten‐induzierte Photosensibilität, also phototoxische oder photoallergische Reaktionen durch Pharmazeutika und nachfolgende Exposition gegenüber ultraviolettem oder sichtbarem Licht, ist eine unerwünschte Wirkung, die zunehmend an Interesse gewinnt.
Georg Amun Hofmann, Benedikt Weber
wiley   +1 more source

Home - About - Disclaimer - Privacy